Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

In a bid to expand its footprint in the emerging markets, Smith & Nephew plc (SNN - Snapshot Report) recently decided to acquire certain assets of its Turkish distributor Plato Grup. The acquisition will promote distribution of Smith & Nephew’s orthopedic reconstruction, trauma and sports medicine products in Turkey.

Financial terms of the deal have not been disclosed. However, the company expects to close this acquisition in the second half of 2013.

Smith & Nephew is encouraged by the potential of this deal, as Turkey is one of the fastest growing emerging markets. Furthermore, Plato’s successful record as well as reputation and business relations will boost the company’s growth in Turkey.

In recent times, Smith & Nephew has undertaken several initiatives to strengthen its product portfolio and expand its global foothold. In May 2013, the company announced an agreement to take over Adler Mediequip Private Limited and with it the brands and assets of Sushrut Surgicals Private Limited, a leader in mid-tier, orthopedic trauma products for the Indian market. The Adler Mediequip buyout gives Smith & Nephew an opportunity to gain a foothold in the growing trauma market in India.

Last month, Smith & Nephew unveiled a strategic partnership to promote its IV3000 range of cannula dressings from its Advanced Wound Management (AWM) franchise in U.K. The company’s persistent focus on the AWM franchise has already begun to yield positive results.

Smith & Nephew also stands to gain from an improved economic overview in the U.S. and stability in the orthorecon market. Meanwhile, the trauma and extremity businesses represent high-growth avenues.

Smith & Nephew currently carries a Zacks Rank #2 (Buy). Other medical stocks such as Natus Medical (BABY - Snapshot Report), Wright Medical Group Inc. (WMGI - Analyst Report) and ResMed Inc. (RMD - Analyst Report) appear impressive. These stocks carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%